SEC Filing | Align Technology

View:

SEC FORM 3 SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Marree Jitse

(Last)

(First)

(Middle)

410 N SCOTTSDALE ROAD

SUITE 1300

(Street)

TEMPE

85288

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
05/01/2026

3. Issuer Name and Ticker or Trading Symbol
ALIGN TECHNOLOGY INC [ ALGN ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
	Officer (give title below)	Other (specify below)
See Remarks

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	2,106	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Restricted Stock Units	⁽¹⁾	⁽¹⁾	Common Stock	226	0.0001⁽²⁾	D
Restricted Stock Units	⁽³⁾	⁽³⁾	Common Stock	452	0.0001⁽²⁾	D
Restricted Stock Units	⁽⁴⁾	⁽⁴⁾	Common Stock	1,377	0.0001⁽²⁾	D
Restricted Stock Units	⁽⁵⁾	⁽⁵⁾	Common Stock	2,774	0.0001⁽²⁾	D
Market Stock Units	⁽⁶⁾	⁽⁶⁾	Common Stock	1,837	0.0001⁽²⁾	D
Market Stock Units	⁽⁷⁾	⁽⁷⁾	Common Stock	2,774	0.0001⁽²⁾	D

Explanation of Responses:

1. On February 20, 2023, the reporting person received an award of 906 restricted stock units ("RSUs"), vesting 25% on each anniversary of the grant date. The remaining 226 unvested shares will vest in full on February 20, 2027, and shares will be delivered to the reporting person on such vesting date.

2. Represents par value of ALGN common stock.

3. On February 20, 2024, the reporting person received an award of 905 RSUs, vesting 25% on each anniversary of the grant date. The remaining 452 unvested shares will vest in equal installments on February 20, 2027 and February 20, 2028, and shares will be delivered to the reporting person on each such vesting date.

4. On February 20, 2025, the reporting person received an award of 1,837 RSUs, vesting 25% on each anniversary of the grant date. The remaining 1,377 unvested shares will vest in equal installments on February 20, 2027, February 20, 2028, and February 20, 2029, and shares will be delivered to the reporting person on each such vesting date.

5. On February 20, 2026, the reporting person received an award of 2,774 RSUs, vesting 25% on each anniversary of the grant date, and shares will be delivered to the reporting person on each such vesting date.

6. Represents the number of shares which may be issued at target pursuant to the market stock units granted on February 20, 2025. If performance exceeds target, the maximum number of shares that may vest is 250% of the at target amount. Vesting, if any, of the market stock units occurs on the last day of the third year of the Performance Period (as defined in the market stock unit agreement).

7. Represents the number of shares which may be issued at target pursuant to the market stock units granted on February 20, 2026. If performance exceeds target, the maximum number of shares that may vest is 250% of the at target amount. Vesting, if any, of the market stock units occurs on the last day of the third year of the Performance Period (as defined in the market stock unit agreement).

Remarks:

The reporting person is Executive Vice President, Global Operations. Exhibit List 24 - Limited Power of Attorney

	/s/Julie Ann Coletti, Attorney-in-Fact for Jitse Marree	05/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

EX-24

Exhibit 24

Limited Power of Attorney (Securities Law Compliance)

The undersigned, as an officer of Align Technology, Inc. (the “Company”), hereby constitutes and appoints John Morici, Julie Ann Coletti and Paul Katawicz, and each of them, the undersigned’s true and lawful attorney-in-fact and agent to complete and execute such Forms 144, Forms 3, 4 and 5 and other forms as such attorney shall in his or her discretion determine to be required or advisable pursuant to Rule 144 promulgated under the Securities Act of 1933, as amended, Section 16 of the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder, or any successor laws and regulations, as a consequence of the undersigned’s ownership, acquisition or disposition of securities of the Company, and to do all acts necessary in order to file such forms with the Securities and Exchange Commission, any securities exchange or national association, the Company and such other person or agency as the attorney shall deem appropriate. The undersigned hereby ratifies and confirms all that said attorneys-in-fact and agents shall do or cause to be done by virtue hereof.

This Limited Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4 and 5 with respect to the undersigned’s holdings of and transactions in securities issued by the Company unless earlier revoked by the undersigned in a writing delivered to the foregoing attorneys-in-fact.

This Limited Power of Attorney is executed at Tempe, Arizona, as of the date set forth below.

/s/ Jitse Marree

Signature

Jitse Marree

Type or Print Name

Dated: May 5, 2026

Witness:

/s/ Michael Robert Duval

Signature

Michael Robert Duval

Type or Print Name

Dated: May 5, 2026